Hepatitis E virus seroprevalence in the United States: No easy answers

Authors


  • Dr. Kuniholm is supported in part by the National Center for Advancing Translational Sciences (NCATS), through CTSA grant numbers UL1RR025750 and KL2RR025749. Mr. Engle and Dr. Purcell are supported in part by the Intramural Research Program of the National Institute of Allergy and Infectious Diseases. Dr. Nelson is supported in part by grant R21HL121740 and the Bill and Melinda Gates Foundation.

  • Potential conflict of interest: Nothing to report.

No abstract is available for this article.

Ancillary